Literature DB >> 3544279

Complement activation and complement receptors in systemic lupus erythematosus.

J P Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3544279     DOI： 10.1007/BF02099021

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  54 in total

1.  The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus.

Authors:  J H VAUGHAN; T B BAYLES; C B FAVOUR
Journal:  J Lab Clin Med       Date:  1951-05

2.  Complement receptor structure and function.

Authors:  G D Ross; J P Atkinson
Journal:  Immunol Today       Date:  1985-04

3.  The efficiency of complement activation in MHC-linked diseases.

Authors:  A E Davis
Journal:  Immunol Today       Date:  1983-09

4.  Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies.

Authors:  T T Provost; F C Arnett; M Reichlin
Journal:  Arthritis Rheum       Date:  1983-10

6.  Primate erythrocyte-immune complex-clearing mechanism.

Authors:  J B Cornacoff; L A Hebert; W L Smead; M E VanAman; D J Birmingham; F J Waxman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

7.  Scleroderma: possible significance of silent alleles at the C4B locus.

Authors:  E Mollenhauer; R Schmidt; M Heinrichs; C Rittner
Journal:  Arthritis Rheum       Date:  1984-06

8.  Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.

Authors:  J G Wilson; R M Jack; W W Wong; P H Schur; D T Fearon
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

10.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).

Authors:  W Lloyd; P H Schur
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889
View more
  12 in total

1.  Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.

Authors:  R P Taylor; W M Sutherland; C J Reist; D J Webb; E L Wright; R H Labuguen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Immune complex processing in C1q-deficient mice.

Authors:  J T Nash; P R Taylor; M Botto; P J Norsworthy; K A Davies; M J Walport
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease?

Authors:  S Clemenceau; F Castellano; M Montes de Oca; C Kaplan; F Danon; M Levy
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

4.  Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains.

Authors:  J H Passwell; G F Schreiner; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

5.  Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study.

Authors:  K Hartung; A Fontana; M Klar; H Krippner; K Jörgens; B Lang; H H Peter; W J Pichler; D Schendel; M Robin-Winn
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 6.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

7.  Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.

Authors:  C Olive; P A Gatenby; S W Serjeantson
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

8.  In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

Authors:  R P Kimberly; J C Edberg; L T Merriam; S B Clarkson; J C Unkeless; R P Taylor
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

Review 9.  Resveratrol Role in Autoimmune Disease-A Mini-Review.

Authors:  Ana Lígia de Brito Oliveira; Valter Vinicius Silva Monteiro; Kely Campos Navegantes-Lima; Jordano Ferreira Reis; Rafaelli de Souza Gomes; Dávila Valentina Silva Rodrigues; Silvia Letícia de França Gaspar; Marta Chagas Monteiro
Journal:  Nutrients       Date:  2017-12-01       Impact factor: 5.717

10.  Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.

Authors:  Alfred H J Kim; Vibeke Strand; Deepali P Sen; Qiang Fu; Nancy L Mathis; Martin J Schmidt; Robin R Bruchas; Nick R Staten; Paul K Olson; Chad M Stiening; John P Atkinson
Journal:  Arthritis Rheumatol       Date:  2019-01-24       Impact factor: 10.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.